Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 2INDIV 1FED 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Mycophenolic Acid 1Immunoglobulins 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Myasthenia Gravis × Mycophenolic Acid × Clear all
NCT00285350 2015-03-25

Mycophenolate Mofetil in Myasthenia Gravis

FDA Office of Orphan Products Development

Phase 3 Completed
80 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡